when does the patent on tirzepatide expire In weight loss battle, Novo and Lilly face growing offensive from licensed copies Can any patent lawyers give

You may have heard about medications like Ozempic, Wegovy, Zepbound and Mounjaro that have surged in popularity as more people look for additional options to help lose weight and manage chronic conditions

:

External resources ATTAIN-1 Trial: Orforglipron for Obesity Treatment (New England Journal of Medicine) SURMOUNT-1 Trial: Tirzepatide for Obesity (New England Journal of Medicine) GLP-1 Receptor Agonists for Type 2 Diabetes and Obesity Review (PubMed Central) For researchers serious about optimizing their GLP-1 protocols and understanding how these medications fit into a comprehensive weight management strategy, SeekPeptides offers the most comprehensive resource available

We performed separate analyses based on type of comparator (placebo, GLP-1 RA or basal insulin) and subgroup analyses based on tirzepatide maintenance dose (5, 10 or 15 mg once-weekly)